Answers are grounded in this paper and cite their sources.
Surgical reconstruction for anterior cruciate ligament (ACL) injuries has been demonstrated to be a reliable and effective treatment that provides satisfactory results.Despite its successful outcomes, bone tunnel enlargement is a concerning complication following ACL reconstruction (ACLR) that has been reported over several years.Various biologic augmentation techniques have been implemented to address this concern.Recently, fibrin clot augmentation has been employed to promote bone and tendon healing; despite its lack of clinical relevance, it was ultimately found to reduce tunnel widening following ACL reconstruction.In the setting of biologic augmentation for ACLR, a thorough assessment of various factors such as efficacy, expense, and possible risks is crucial.Additional clinical studies are needed to elucidate whether current and emerging bioaugmentation techniques are truly beneficial for patients requiring ACLR.
No takes yet. Share an insight, caveat, or question.
Cheon et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: